Frontlight ResearchEarly access
Trial site
University of Rochester James P Wilmot Cancer Institute
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Diffuse large B-cell lymphoma1 trial
- Multiple myeloma1 trial
- Phase
- Phase 11 trial
- Status
- Active, not recruiting2 trials
- Lead sponsor
- Duke University1 trial
- Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1 trial
Running trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026